Docetaxel ntụ ntụ CAS 114977-28-5 GMP mmepụta ihe mgbochi ọrịa cancer dị elu.

Nkọwa dị mkpirikpi:

Ụdị mgbochi tumor nke Docetaxel siri ike karịa nke paclitaxel.Cetaxel nwere ike ịmepụta ngwugwu microtubule kwụsiri ike na-adịghị arụ ọrụ site na ịkwalite tubulin polymerization na igbochi microtubule depolymerization, si otú ahụ na-ebibi mitosis nke mkpụrụ ndụ tumo ma nweta mmetụta mgbochi tumor.Mmetụta.Ụlọ ọrụ Hande Bio GMP na-enye mgbochi ọrịa cancer docetaxel ntụ ntụ CAS 114977-28-5 dị elu.Maka nkọwa ndị ọzọ, biko kpọtụrụ anyị n'ịntanetị.


Nkọwa ngwaahịa

Mkpado ngwaahịa

Ozi ngwaahịa

Aha:Docetaxel

Nọmba CAS:114977-28-5

Usoro kemịkalụ:C45H57NO14

Nkọwapụta:99%

Agba:ọcha ntụ ntụ

Isi mmalite:Semi-synthesized na 10-DAB

Ụdị:API

Ọrụ

Maka ọgwụgwọ ọrịa kansa ara dị elu, ọrịa kansa akpa ume na-abụghị obere cell.A na-ejikwa ya na-agwọ etuto dị ka kansa isi na olu, ọrịa cancer akpa ume obere cell, ọrịa afọ afọ, na ọrịa cancer ovarian.

Dị ka paclitaxel, ọ na-enwe mmetụta dị mma na ọrịa cancer akpa ume na-abụghị obere cell na ọrịa ara ara, a pụkwara iji ya mee ihe maka ọrịa cancer isi na olu na ọrịa cancer ovarian.

Mpaghara ngwa

Ụlọ ọrụ ọgwụ

Ụlọ ọrụ Hande

Yunnan hande Biotechnology Co., Ltd., tọrọ ntọala na August 1993, bụ ụlọ ọrụ teknụzụ dị elu nke ọkachamara na nyocha na mmepe biotechnology.Mgbe ọtụtụ afọ nke mmepe gasịrị, hande eguzobewo usoro dị mma zuru oke, na-achịkwa àgwà ngwaahịa dịka ụkpụrụ dị elu si dị, ma mee ka uru mmepụta nke mmepụta ihe dị elu.Ngwaahịa ya agafeela asambodo nke iwu na ụkpụrụ mba dị iche iche, wee bụrụ onye nrụpụta akụrụngwa akụrụngwa nke na-eme onye ọ bụla nwee ahụ iru ala.

Ụlọ ọrụ Hande

Bụrụ onye na-ebubata akụrụngwa na ụlọ ọrụ na-eguzosi ike n'ezi ihe!

Nnọọ ịkpọtụrụ m site na izipu email namarketing@handebio.com


  • Nke gara aga:
  • Osote: